ES8700936A1 - Un metodo de producir una composicion farmaceutica estabili-zada - Google Patents
Un metodo de producir una composicion farmaceutica estabili-zadaInfo
- Publication number
- ES8700936A1 ES8700936A1 ES540907A ES540907A ES8700936A1 ES 8700936 A1 ES8700936 A1 ES 8700936A1 ES 540907 A ES540907 A ES 540907A ES 540907 A ES540907 A ES 540907A ES 8700936 A1 ES8700936 A1 ES 8700936A1
- Authority
- ES
- Spain
- Prior art keywords
- zada
- stabili
- producing
- pharmaceutical composition
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000002253 acid Substances 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000010494 dissociation reaction Methods 0.000 abstract 1
- 230000005593 dissociations Effects 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 229940049964 oleate Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59043265A JPS60185727A (ja) | 1984-03-05 | 1984-03-05 | ４−カルバモイルイミダゾリウム−５−オレ−ト製剤の安定化法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES540907A0 ES540907A0 (es) | 1986-11-16 |
| ES8700936A1 true ES8700936A1 (es) | 1986-11-16 |
Family
ID=12659008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES540907A Expired ES8700936A1 (es) | 1984-03-05 | 1985-03-04 | Un metodo de producir una composicion farmaceutica estabili-zada |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0159777A1 (enExample) |
| JP (1) | JPS60185727A (enExample) |
| KR (1) | KR850006131A (enExample) |
| CA (1) | CA1235065A (enExample) |
| ES (1) | ES8700936A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR950010150B1 (ko) * | 1986-01-14 | 1995-09-11 | 쥬우가이세이야꾸 가부시끼가이샤 | 니코란딜 함유 주사제의 안정화 방법 |
| JP5266010B2 (ja) * | 2007-09-14 | 2013-08-21 | 富士フイルム株式会社 | ４−カルバモイル−５−ヒドロキシ−イミダゾール誘導体のスルホン酸塩化合物 |
| JP5458777B2 (ja) | 2009-09-28 | 2014-04-02 | 株式会社ジェイテクト | ダブルカルダンジョイントのカップリングヨーク |
| JP2013082706A (ja) * | 2011-09-28 | 2013-05-09 | Fujifilm Corp | ５−ヒドロキシ−１ｈ−イミダゾール−４−カルボキサミド水和物の結晶 |
| TWI594988B (zh) * | 2011-09-28 | 2017-08-11 | 富士軟片股份有限公司 | ５－羥基－１ｈ－咪唑－４－甲醯胺．３／４水合物及其結晶之製造方法 |
| RU2630682C2 (ru) | 2011-09-28 | 2017-09-12 | Фуджифилм Корпорэйшн | Кристалл 5-гидрокси-1н-имидазол-4-карбоксамид•3/4 гидрата, способ его получения и кристалл 5-гидрокси-1н-имидазол-4-карбоксамида гидрата |
| BR112014026250A2 (pt) * | 2013-01-15 | 2017-06-27 | Fujifilm Corp | preparação de produto sólido embalado contendo 5-hidroxi-1h-imidazola-4-carboxamida ou sal do mesmo, ou hidrato dos mesmos |
| RU2603137C1 (ru) * | 2013-01-15 | 2016-11-20 | Фуджифилм Корпорэйшн | Сульфат 5-гидрокси-1н-имидазол-4-карбоксамида |
| SI2946780T1 (sl) | 2013-01-15 | 2017-05-31 | Fujifilm Corporation | Tableta, ki vsebuje 5-hidroksi-1h-imidazol-4-karboksamid |
| EP3686189B1 (en) * | 2017-10-27 | 2021-09-01 | FUJIFILM Corporation | Production method for 5-hydroxy-1h-imidazole-4-carboxamide-3/4hydrate |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4181731A (en) * | 1976-09-07 | 1980-01-01 | Sumitomo Chemical Company, Limited | Novel therapeutic application of 4-carbamoyl-5-hydroxyimidazole |
| DE3176849D1 (en) * | 1980-11-05 | 1988-09-29 | Sumitomo Chemical Co | Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate |
-
1984
- 1984-03-05 JP JP59043265A patent/JPS60185727A/ja active Granted
-
1985
- 1985-02-21 EP EP85301164A patent/EP0159777A1/en not_active Ceased
- 1985-02-27 CA CA000475351A patent/CA1235065A/en not_active Expired
- 1985-03-04 ES ES540907A patent/ES8700936A1/es not_active Expired
- 1985-03-04 KR KR1019850001346A patent/KR850006131A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA1235065A (en) | 1988-04-12 |
| KR850006131A (ko) | 1985-10-02 |
| ES540907A0 (es) | 1986-11-16 |
| JPS60185727A (ja) | 1985-09-21 |
| EP0159777A1 (en) | 1985-10-30 |
| JPH0137376B2 (enExample) | 1989-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230404868A1 (en) | Cosmetic Material Composition | |
| DE69000645T2 (de) | Bei kuehlschranktemperatur stabile waessrige folinatloesung sowie verfahren zu deren herstellung. | |
| ES8700936A1 (es) | Un metodo de producir una composicion farmaceutica estabili-zada | |
| ES8600051A1 (es) | Procedimiento de obtencion de composiciones farmaceuticas a base de derivados de acido glicirretinico. | |
| AR007715A1 (es) | Formulacion acuosa estable de un peptido, un metodo para preparar la misma y su uso para tratamiento | |
| MX169758B (es) | Procedimiento para preparar un concentrado transparente y estable al almacenamiento | |
| UY27320A1 (es) | Nuevas composiciones farmacéuticas | |
| CO5210868A1 (es) | Composiciones que tienen estabilidad mejorada | |
| MX3351E (es) | Procedimiento mejorado para la preparacion de una solucion acuosa de doxiciclina | |
| ES8205855A1 (es) | Un procedimiento para la preparacion y estabilizacion de una composicion blanqueante acuosa que contiene peroxido de hi-drogeno. | |
| ES2002302A6 (es) | Una capsula de gelatina dura que contiene una composicion masticable | |
| BR9713503A (pt) | Composições fertilizantes incluindo ìons metálicos quelados | |
| PE20051131A1 (es) | COMPOSICIONES ANTIPERSPIRANTES CON pH ELEVADO DE EFICACIA MEJORADA | |
| ES8500738A1 (es) | Un procedimiento para la preparacion de una composicion antiinflamatoria topica como unguento en forma de gel | |
| EP0208519A3 (en) | Solubilized composition of hardly-soluble pharmaceutical product | |
| PT1465663E (pt) | Soluções injectáveis prontas a usar de paracetamol contendo propilenoglicol como o único co-solvente | |
| ES8700054A1 (es) | Procedimiento de obtencion de germicidas a base de acidos clorhidrico y fosforico. | |
| CA2244389A1 (en) | Cilansetron pharmaceutical preparation stabilized against racemization | |
| ES2089613T3 (es) | Composicion detergente. | |
| JPS56115793A (en) | Phosphonohydroxyacetic acid* its salt* their manufacture and drug thereof as active component | |
| JPS57188515A (en) | Stabilized aqueous dopamine preparation | |
| AR247420A1 (es) | Composicion y procedimiento para corregir la productividad y/o capacidad de inyeccion de pozos de petroleo. | |
| ES8504434A1 (es) | Procedimiento para preparar una composicion fungicida a base de una sal de acido alquil-fosforoso | |
| GB2035801A (en) | Cephradine compositions | |
| DE3536745A1 (de) | Metallkomplexe der bis-indolverbindungen und diese enthaltende arzneimittelpraeparate |